Want to join the conversation?
$HALO's cost of product sales were $6.2MM in 3Q15 compared to $5.1MM in 3Q14. The increase of $1.1MM was due to a $1.2MM increase in bulk rHuPH20 sales to collaboration partners offset by a $0.2MM decrease in Hylenex recombinant cost of product sales. The company's interest expense remained constant at $1.3MM in 3Q15 versus $1.4MM in 3Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?